Gene hunt aims to prevent antidepressant agitation in kids
NCT ID NCT03953014
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a child's genes can predict if they will have certain side effects from common antidepressants (SSRIs). Researchers will collect saliva samples from 120 children and young adults aged 6 to 24 with depression, anxiety, or OCD. The goal is to find genetic markers that could help doctors choose safer treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIDEPRESSANT DRUG ADVERSE REACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Child and Adolescent Addiction, Mental Health & Psychiatry
RECRUITINGCalgary, Alberta, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single ketamine infusion quiet the obsessive mind?
- Can a structured care pathway ease teen depression?
- Middle school jitters: a new program aims to smooth the transition for anxious students
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Can your Child's doctor treat anxiety? a new approach puts it to the test